Download Files:
251 CAD – 3,136 CADPrice range: 251 CAD through 3,136 CAD
Products Details
Product Description
– Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
Web ID
– T9912
Storage Temperature
– -20℃
Shipping
– Blue Ice
Citations
– 1. Wang Z, Gao L, Jia Z, et al.Full-length transcriptome atlas of gallbladder cancer reveals trastuzumab resistance conferred by ERBB2 alternative splicing.Signal Transduction and Targeted Therapy.2025, 10(1): 54.
References
– Zazo S, et al. Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines. Am J Cancer Res. 2016 Nov 1;6(11):2661-2678.
CAS Number
– 180288-69-1
Molecular Weight
Compound Purity
– SDS-PAGE: 97.1%;SEC-HPLC: 99.2%
Pathway
– Tyrosine Kinase/Adaptors|||Angiogenesis|||Antibody-drug Conjugate/ADC Related|||JAK/STAT signaling
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock